Buscar | MyLiveRoom

Rishika Datta agregó una foto Health
2026-03-13 09:25:33 - Translate -

Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma Therapies
According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Naznin Shaikh agregó una foto Film
2026-03-06 08:53:40 - Translate -

Emerging Trends Influencing the Antibody Drug Conjugates Market
Asia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...

0 Commentarios 0 Acciones 4K Views 0 Vista previa

Please log in to like, share and comment!
Naznin Shaikh agregó una foto Networking
2026-03-09 10:07:13 - Translate -

Future Market Potential of Chemotherapy-Induced Peripheral Neuropathy Treatments
The global chemotherapy-induced peripheral neuropathy market size is projected to grow from US$ 1.01 billion in 2025 to approximately US$ 1.67 billion by 2034, reflecting a steady expansion. The market is anticipated to register a compound annual growth rate (CAGR) of around 5.71% during the forecast period, highlighting increasing investments in oncology supportive care. The...

0 Commentarios 0 Acciones 3K Views 0 Vista previa

Please log in to like, share and comment!
Rishika Datta agregó una foto Health
2026-03-16 06:24:30 - Translate -

Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology Adoption
According to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...

0 Commentarios 0 Acciones 1K Views 0 Vista previa

Please log in to like, share and comment!
Naznin Shaikh agregó una foto Juegos
2026-03-09 08:27:37 - Translate -

Global CAR-T Cell Therapy Market Growth at 17.5% CAGR Through 2030
Increasing research and development activities in cell-based therapies are supporting the expansion of the CAR-T cell therapy market. Pharmaceutical and biotechnology companies are investing heavily in clinical trials and advanced technologies. These efforts are accelerating the development of new and effective cancer treatments. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030...

0 Commentarios 0 Acciones 4K Views 0 Vista previa

Please log in to like, share and comment!
Naznin Shaikh agregó una foto Health
2026-03-12 10:55:52 - Translate -

Global High Potent API (HPAPI) Market — Trends and Market Leaders & Key Company Profiles
The global high potent API (HPAPI) market is experiencing exceptional growth momentum, driven by the surging demand for targeted cancer therapies, rapid advancements in containment and manufacturing technologies, and a structural shift toward outsourced pharmaceutical production. According to The Insight Partners, the high potent API market was valued at US$ 28.82 Billion in...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Mehul Buwa agregó una foto Networking
2025-06-24 10:23:53 - Translate -

Global Somatostatin Analogs Market Poised for Steady Growth.
The global somatostatin analogs market is experiencing robust growth, fueled by the increasing prevalence of hormonal disorders such as acromegaly and neuroendocrine tumors. These synthetic peptides mimic natural somatostatin, a hormone that inhibits the release of several other hormones, thus playing a crucial role in managing complex endocrine conditions. Market Drivers One of the...

0 Commentarios 0 Acciones 6K Views 0 Vista previa

Please log in to like, share and comment!
Naznin Shaikh agregó una foto Fitness
2026-03-06 09:22:35 - Translate -

Immunotherapy Impact on the Anti-cancer Drugs Market
The rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...

0 Commentarios 0 Acciones 3K Views 0 Vista previa

Please log in to like, share and comment!
Rishika Datta agregó una foto Other
2026-03-13 10:10:59 - Translate -

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!